Trial Profile
An observational study to determine the prognostic factors for uveitis in patients with behcet's Disease who were treated with infliximab.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Behcet's syndrome
- Focus Therapeutic Use
- 05 Dec 2015 New trial record